In order to analyze the molecular mechanism of CRABP2 regulating drug resistance in ovarian cancer, we conducted enrichment analysis on gene data from TCGA database, and found that CRABP2 may be involved in the metabolic regulation of ovarian cancer cells. Here, CRABP2 is linked to ovarian cancer.